Log in to your account:
Celgene (CELG) Stockholders Approve Acquisition by Bristol-Myers Squibb (BMY)
April 12, 2019 10:34 AM
Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Mergers and Acquisitions
Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb
April 12, 2019 10:33 AM